123 related articles for article (PubMed ID: 17659733)
1. Association of ezrin expression in intestinal and diffuse gastric carcinoma with clinicopathological parameters and tumor type.
Bal N; Yildirim S; Nursal TZ; Bolat F; Kayaselcuk F
World J Gastroenterol; 2007 Jul; 13(27):3726-9. PubMed ID: 17659733
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of ezrin via RNA interference suppresses Helicobacter pylori-enhanced invasion of gastric cancer cells.
Fan LL; Chen DF; Lan CH; Liu KY; Fang DC
Cancer Biol Ther; 2011 Apr; 11(8):746-52. PubMed ID: 21282970
[TBL] [Abstract][Full Text] [Related]
3. Relationship of p53 and c-erbB-2 expression to histopathological features, Helicobacter pylori infection and prognosis in gastric cancer.
Shun CT; Wu MS; Lin JT; Chen SY; Wang HP; Lee WJ; Wang TH; Chuang SM
Hepatogastroenterology; 1997; 44(14):604-9. PubMed ID: 9164544
[TBL] [Abstract][Full Text] [Related]
4. Correlation of decreased expression of PHLDA1 protein with malignant phenotype of gastric adenocarcinoma.
Zhao P; Lu Y; Liu L
Int J Clin Exp Pathol; 2015; 8(5):5230-5. PubMed ID: 26191222
[TBL] [Abstract][Full Text] [Related]
5. Is Helicobacter Pylori associated with Her2/neu Overexpression in Gastric Cancer Patients who Underwent Curative Resection?
Yoo MW; Han HS; Kim SY; Cho YH; Lee HG; Kim JH; Bang HY; Lee KY; Yoon SY
Hepatogastroenterology; 2014 May; 61(131):858-62. PubMed ID: 26176087
[TBL] [Abstract][Full Text] [Related]
6. Ezrin overexpression predicts the poor prognosis of gastric adenocarcinoma.
Jin J; Jin T; Quan M; Piao Y; Lin Z
Diagn Pathol; 2012 Oct; 7():135. PubMed ID: 23039327
[TBL] [Abstract][Full Text] [Related]
7. Unclassified mucin phenotype of gastric adenocarcinoma exhibits the highest invasiveness.
Han HS; Lee SY; Lee KY; Hong SN; Kim JH; Sung IK; Park HS; Jin CJ; Min YI
J Gastroenterol Hepatol; 2009 Apr; 24(4):658-66. PubMed ID: 19175827
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical expression of Fhit protein in Helicobacter pylori related chronic gastritis, gastric precancerous lesions and gastric carcinoma: correlation with conventional clinicopathologic parameters.
Skopelitou AS; Mitselou A; Katsanos KH; Alexopoulou V; Tsianos EV
Eur J Gastroenterol Hepatol; 2003 May; 15(5):515-23. PubMed ID: 12702909
[TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase-2 expression and its association with angiogenesis, Helicobacter pylori, and clinicopathologic characteristics of gastric carcinoma.
Yamac D; Ayyildiz T; Coşkun U; Akyürek N; Dursun A; Seckin S; Koybasioglu F
Pathol Res Pract; 2008; 204(8):527-36. PubMed ID: 18462890
[TBL] [Abstract][Full Text] [Related]
10. RUNX3 Methylation, Loss of RUNX3 Expression and Clinicopathologic Findings according to Helicobacter pylori CagA in Gastric Carcinoma.
Na YJ; Shim KN; Joo YH; Kim SE; Jung HK; Jung SA; Cho MS
Korean J Gastroenterol; 2015 Aug; 66(2):75-84. PubMed ID: 26289240
[TBL] [Abstract][Full Text] [Related]
11. Fhit expression in gastric adenocarcinoma: correlation with disease stage and survival.
Capuzzi D; Santoro E; Hauck WW; Kovatich AJ; Rosato FE; Baffa R; Huebner K; McCue PA
Cancer; 2000 Jan; 88(1):24-34. PubMed ID: 10618602
[TBL] [Abstract][Full Text] [Related]
12. Arp2/3 overexpression contributed to pathogenesis, growth and invasion of gastric carcinoma.
Zheng HC; Zheng YS; Li XH; Takahashi H; Hara T; Masuda S; Yang XH; Guan YF; Takano Y
Anticancer Res; 2008; 28(4B):2225-32. PubMed ID: 18751399
[TBL] [Abstract][Full Text] [Related]
13. Expression of nuclear factor-kappa B and target genes in gastric precancerous lesions and adenocarcinoma: association with Helicobactor pylori cagA (+) infection.
Yang GF; Deng CS; Xiong YY; Gong LL; Wang BC; Luo J
World J Gastroenterol; 2004 Feb; 10(4):491-6. PubMed ID: 14966904
[TBL] [Abstract][Full Text] [Related]
14. [Expression of Ezrin in gastric carcinoma and its significance].
Shi RL; Li JF; Qu Y; Chen XH; Gu QL; Zhu ZG; Liu BY
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Sep; 9(5):433-5. PubMed ID: 17043968
[TBL] [Abstract][Full Text] [Related]
15. Aberrant Pim-3 expression is involved in gastric adenoma-adenocarcinoma sequence and cancer progression.
Zheng HC; Tsuneyama K; Takahashi H; Miwa S; Sugiyama T; Popivanova BK; Fujii C; Nomoto K; Mukaida N; Takano Y
J Cancer Res Clin Oncol; 2008 Apr; 134(4):481-8. PubMed ID: 17876606
[TBL] [Abstract][Full Text] [Related]
16. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
[TBL] [Abstract][Full Text] [Related]
17. Paradoxical expression of maspin in gastric carcinomas: correlation with carcinogenesis and progression.
Yu M; Zheng H; Tsuneyama K; Takahashi H; Nomoto K; Xu H; Takano Y
Hum Pathol; 2007 Aug; 38(8):1248-55. PubMed ID: 17490717
[TBL] [Abstract][Full Text] [Related]
18. Expression of gastrin and its receptor in human gastric cancer tissues.
Hur K; Kwak MK; Lee HJ; Park DJ; Lee HK; Lee HS; Kim WH; Michaeli D; Yang HK
J Cancer Res Clin Oncol; 2006 Feb; 132(2):85-91. PubMed ID: 16228228
[TBL] [Abstract][Full Text] [Related]
19. Differences in clinicopathological findings, cell kinetics and p53 expression between early gastric cancers with and without Helicobacter pylori infection.
Mitsuhashi J; Mitomi H; Tanabe S; Koizumi W; Kikuchi S; Ojima T; Okayasu I; Saigenji K
Hepatogastroenterology; 2004; 51(60):1636-40. PubMed ID: 15532794
[TBL] [Abstract][Full Text] [Related]
20. Aberrant expression of cortactin and fascin are effective markers for pathogenesis, invasion, metastasis and prognosis of gastric carcinomas.
Li X; Zheng H; Hara T; Takahashi H; Masuda S; Wang Z; Yang X; Guan Y; Takano Y
Int J Oncol; 2008 Jul; 33(1):69-79. PubMed ID: 18575752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
